Another approach for TRAIL delivery utilized exosomes derived from TRAIL-engineered murine BM–MSCs, which significantly reduced tumor volume and induced necrosis in a melanoma mouse model [52]. The gene discussed is TNFSF10; the disease is neoplasm.